Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists - Okamoto, A; Yokokawa, H; Nagamine, T (J Diabetes Metab Disord, 2021)